Benefits, risks of SGLT2 inhibitors explored at session.
作者信息
Caffrey Mary K
出版信息
Am J Manag Care. 2014 Jul;20(10 Spec No):E11.
PMID:25830192
Abstract
摘要
相似文献
1
Benefits, risks of SGLT2 inhibitors explored at session.会议探讨了SGLT2抑制剂的益处和风险。
Am J Manag Care. 2014 Jul;20(10 Spec No):E11.
2
SGLT2 inhibitors in the treatment of type 2 diabetes.钠-葡萄糖协同转运蛋白2抑制剂在2型糖尿病治疗中的应用
Diabetes Res Clin Pract. 2014 Jun;104(3):297-322. doi: 10.1016/j.diabres.2014.02.014. Epub 2014 Mar 11.
3
SGLT2 inhibitors: providing cardiovascular protection in type 2 diabetes?钠-葡萄糖协同转运蛋白2抑制剂：为2型糖尿病提供心血管保护？
Lancet Diabetes Endocrinol. 2016 May;4(5):379-81. doi: 10.1016/S2213-8587(16)00084-X. Epub 2016 Mar 18.
4
SGLT2 inhibitors to control glycemia in type 2 diabetes mellitus: a new approach to an old problem.SGLT2 抑制剂控制 2 型糖尿病患者的血糖：一个老问题的新方法。
Postgrad Med. 2014 Jan;126(1):111-7. doi: 10.3810/pgm.2014.01.2731.
5
Practical considerations for the use of sodium-glucose co-transporter type 2 inhibitors in treating hyperglycemia in type 2 diabetes.2型糖尿病中使用钠-葡萄糖协同转运蛋白2抑制剂治疗高血糖的实际考量
Curr Med Res Opin. 2016 Jun;32(6):1097-108. doi: 10.1185/03007995.2016.1161608. Epub 2016 Apr 4.
6
Renal glucose reabsorption inhibitors to treat diabetes.用于治疗糖尿病的肾葡萄糖重吸收抑制剂。
Trends Pharmacol Sci. 2011 Feb;32(2):63-71. doi: 10.1016/j.tips.2010.11.011. Epub 2011 Jan 4.
7
SGLT2 inhibitors: the latest "new kids on the block"!钠-葡萄糖协同转运蛋白2抑制剂：最新的“新成员”！
Diabetes Care. 2015 Mar;38(3):352-4. doi: 10.2337/dc14-3048.
8
[Sodium Glucose Co-transporter Type 2 (SGLT2) Inhibitors in CKD].[2型钠-葡萄糖协同转运蛋白（SGLT2）抑制剂在慢性肾脏病中的应用]
G Ital Nefrol. 2015 Jul-Aug;32(4).
9
Effects of SGLT2 inhibitors on weight loss in patients with type 2 diabetes mellitus.钠-葡萄糖协同转运蛋白2抑制剂对2型糖尿病患者体重减轻的影响。
Eur Rev Med Pharmacol Sci. 2017 Jan;21(1):199-211.
10
[SGLT2 inhibitors: a new therapeutic class for the treatment of type 2 diabetes mellitus].[钠-葡萄糖协同转运蛋白2抑制剂：治疗2型糖尿病的新型治疗类别]
Harefuah. 2015 Mar;154(3):200-3, 210.
Zotero 插件